NCT01961830View on ClinicalTrials.gov

Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2013

Conditions
Healthy
Interventions
DRUG

ME1100 inhalation solution

Trial Locations (1)

Unknown

Pulmonary Associates, Phoenix

Sponsors
All Listed Sponsors
lead

Meiji Seika Pharma Co., Ltd.

INDUSTRY